Company: NHICW
Filing Date: 2025-01-17
Form Type: S-1/A
Source: 0001213900-25-004337
Chunk: 40

Company: NewHold Investment Corp. III
Filing Date: 2025-01-17
Form: S-1/A
Chunk 40
---
 units allocated to them in connection with the closing of this offering as described below, the sponsor will issue membership interests at a nominal purchase price to the non -managingsponsor investors at the closing of this offering reflecting indirect interests in an aggregate of [_] founder shares (or [_] founder shares if the over -allotmentoption is exercised in full) held by the sponsor. (2)The non -managingsponsor investors have expressed an interest to purchase, indirectly through the purchase of non -managingmembership interests, an aggregate of 422,500 private units ($4,225,000 in the aggregate) at a price of $10.00 per unit (or 435,625 warrants ($4,356,250 in the aggregate) if the over -allotmentoption is exercised in full) in a private placement that will close simultaneously with the closing of this offering. (3)As of the date of this prospectus, no such arrangements are currently in place. (4)As of the date of this prospectus, no such arrangements are currently in place. Any such salary or fee would be paid using available working capital funds (including proceeds from any promissory notes issued by us and funds released from the trust account upon completion of our initial business combination), but would not in any event be paid out of the administrative services fee. Because our sponsor acquired the founder shares at a nominal price ($0.004 per share), our public shareholders will incur immediate and substantial dilution upon the closing of this offering, assuming no value is ascribed to the warrants included in the units. Further, the Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti -dilutionrights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion. Additionally, our public shareholders may experience dilution from the exercise of the 356,250 private warrants (389,062 private warrants if the underwriters’ over -allotmentoption is exercised in full) that compose part of the private units to be purchased by our sponsor simultaneously with the closing of this offering as well as conversion of any working capital loans into units, if elected by the sponsor or by another person or entity who made such working capital loans. The exercise of the warrants would cause the actual dilution to the public shareholders to be higher, particularly where a cashless exercise is utilized. See the